Drugs / CIB in vivo CAR-T Lentiviral Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07657585 | Jul 2026 → Jun 2027 expected | cancer | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CIB in vivo CAR-T Lentiviral Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07657585 ↗ |
| Route | Intravenous | “administered via intravenous infusion” NCT07657585 ↗ |